{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:11:37Z","timestamp":1793067097747,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12974-015-0369-6","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T19:50:51Z","timestamp":1439581851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"12","author":[{"given":"Christine","family":"Landlinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Oberleitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Noiges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyna","family":"Yatsyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radmila","family":"Santic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Mandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther","family":"Staffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,16]]},"reference":[{"key":"369_CR1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1567205012666141218140953","volume":"12","author":"RJ Baranello","year":"2015","unstructured":"Baranello RJ, Bharani KL, Padmaraju V, Chopra N, Lahiri DK, Greig NH, et al. Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer\u2019s disease. Curr Alzheimer Res. 2015;12:32\u201346.","journal-title":"Curr Alzheimer Res"},{"key":"369_CR2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-130653","volume":"37","author":"A Takashima","year":"2013","unstructured":"Takashima A. Tauopathies and tau oligomers. J Alzheimers Dis. 2013;37:565\u20138.","journal-title":"J Alzheimers Dis"},{"key":"369_CR3","doi-asserted-by":"crossref","unstructured":"Latta CH, Brothers HM, Wilcock DM. Neuroinflammation in Alzheimer\u2019s disease. A source of heterogeneity and target for personalized therapy. Neuroscience. 2014.","DOI":"10.1016\/j.neuroscience.2014.09.061"},{"key":"369_CR4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci. 1991;12:383\u20138.","journal-title":"Trends Pharmacol Sci"},{"key":"369_CR5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10:698\u2013712.","journal-title":"Nat Rev Drug Discov"},{"key":"369_CR6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med. 2014;370:311\u201321.","journal-title":"N Engl J Med"},{"key":"369_CR7","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","volume":"65","author":"HJ Aizenstein","year":"2008","unstructured":"Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 2008;65:1509\u201317.","journal-title":"Arch Neurol"},{"key":"369_CR8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ana.23797","volume":"73","author":"CA Mathis","year":"2013","unstructured":"Mathis CA, Kuller LH, Klunk WE, Snitz BE, Price JC, Weissfeld LA, et al. In vivo assessment of amyloid-beta deposition in nondemented very elderly subjects. Ann Neurol. 2013;73:751\u201361.","journal-title":"Ann Neurol"},{"key":"369_CR9","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","volume":"106","author":"M Blurton-Jones","year":"2009","unstructured":"Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Muller FJ, Loring JF, et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A. 2009;106:13594\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"369_CR10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14:463\u201377.","journal-title":"Nat Rev Immunol"},{"key":"369_CR11","first-page":"a006346","volume":"2","author":"T Wyss-Coray","year":"2012","unstructured":"Wyss-Coray T, Rogers J. Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspectives in Medicine. 2012;2:a006346.","journal-title":"Cold Spring Harb Perspectives in Medicine"},{"key":"369_CR12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer\u2019s disease. Neurobiol Aging. 2000;21:383\u2013421.","journal-title":"Neurobiol Aging"},{"key":"369_CR13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/NEN.0b013e3182933788","volume":"72","author":"A Serrano-Pozo","year":"2013","unstructured":"Serrano-Pozo A, Muzikansky A, Gomez-Isla T, Growdon JH, Betensky RA, Frosch MP, et al. Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease. J Neuropathol Exp Neurol. 2013;72:462\u201371.","journal-title":"J Neuropathol Exp Neurol"},{"key":"369_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/neur.1996.0002","volume":"5","author":"H Fukumoto","year":"1996","unstructured":"Fukumoto H, Asami-Odaka A, Suzuki N, Iwatsubo T. Association of A beta 40-positive senile plaques with microglial cells in the brains of patients with Alzheimer\u2019s disease and in non-demented aged individuals. Neurodegeneration. 1996;5:13\u20137.","journal-title":"Neurodegeneration"},{"key":"369_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2010-1414","volume":"21","author":"K Hensley","year":"2010","unstructured":"Hensley K. Neuroinflammation in Alzheimer\u2019s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J Alzheimers Dis. 2010;21:1\u201314.","journal-title":"J Alzheimers Dis"},{"key":"369_CR16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-11-48","volume":"11","author":"D Doens","year":"2014","unstructured":"Doens D, Fernandez PL. Microglia receptors and their implications in the response to amyloid beta for Alzheimer\u2019s disease pathogenesis. J Neuroinflammation. 2014;11:48.","journal-title":"J Neuroinflammation"},{"key":"369_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-5-9","volume":"5","author":"DA Loeffler","year":"2008","unstructured":"Loeffler DA, Camp DM, Bennett DA. Plaque complement activation and cognitive loss in Alzheimer\u2019s disease. J Neuroinflammation. 2008;5:9.","journal-title":"J Neuroinflammation"},{"key":"369_CR18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1385-299X(96)00026-8","volume":"1","author":"Y Shen","year":"1997","unstructured":"Shen Y, Halperin JA, Benzaquen L, Lee CM. Characterization of neuronal cell death induced by complement activation. Brain Res Brain Res Protoc. 1997;1:186\u201394.","journal-title":"Brain Res Brain Res Protoc"},{"key":"369_CR19","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.neurobiolaging.2014.06.004","volume":"35","author":"M Orre","year":"2014","unstructured":"Orre M, Kamphuis W, Osborn LM, Jansen AH, Kooijman L, Bossers K, et al. Isolation of glia from Alzheimer\u2019s mice reveals inflammation and dysfunction. Neurobiol Aging. 2014;35:2746\u201360.","journal-title":"Neurobiol Aging"},{"key":"369_CR20","doi-asserted-by":"crossref","unstructured":"Ager RR, Fonseca MI, Chu SH, Sanderson SD, Taylor SM, Woodruff TM, et al. Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer\u2019s disease. J Neurochem. 2010;113:389\u2013401.","DOI":"10.1111\/j.1471-4159.2010.06595.x"},{"key":"369_CR21","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1096\/fj.05-5814com","volume":"20","author":"TM Woodruff","year":"2006","unstructured":"Woodruff TM, Crane JW, Proctor LM, Buller KM, Shek AB, de Vos K, et al. Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. FASEB J. 2006;20:1407\u201317.","journal-title":"FASEB J"},{"key":"369_CR22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","volume":"183","author":"MI Fonseca","year":"2009","unstructured":"Fonseca MI, Ager RR, Chu SH, Yazan O, Sanderson SD, LaFerla FM, et al. Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer\u2019s disease. J Immunol. 2009;183:1375\u201383.","journal-title":"J Immunol"},{"key":"369_CR23","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.neurobiolaging.2007.02.017","volume":"29","author":"D Ryman","year":"2008","unstructured":"Ryman D, Gao Y, Lamb BT. Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2008;29:1190\u20138.","journal-title":"Neurobiol Aging"},{"key":"369_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99\u2013102.","journal-title":"Science"},{"key":"369_CR25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainres.2009.11.040","volume":"1311","author":"NR Rustay","year":"2010","unstructured":"Rustay NR, Cronin EA, Curzon P, Markosyan S, Bitner RS, Ellis TA, et al. Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer\u2019s disease. Brain Res. 2010;1311:136\u201347.","journal-title":"Brain Res"},{"key":"369_CR26","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4161\/hv.6.11.13217","volume":"6","author":"A Schneeberger","year":"2010","unstructured":"Schneeberger A, Mandler M, Mattner F, Schmidt W. AFFITOME(R) technology in neurodegenerative diseases: the doubling advantage. Hum Vaccin. 2010;6:948\u201352.","journal-title":"Hum Vaccin"},{"key":"369_CR27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3233\/JAD-2011-111208","volume":"28","author":"M Mandler","year":"2012","unstructured":"Mandler M, Rockenstein E, Ubhi K, Hansen L, Adame A, Michael S, et al. Detection of peri-synaptic amyloid-beta pyroglutamate aggregates in early stages of Alzheimer\u2019s disease and in AbetaPP transgenic mice using a novel monoclonal antibody. J Alzheimers Dis. 2012;28:783\u201394.","journal-title":"J Alzheimers Dis"},{"key":"369_CR28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2001.7732","volume":"171","author":"LF Lue","year":"2001","unstructured":"Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, et al. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer\u2019s disease: identification of a cellular activation mechanism. Exp Neurol. 2001;171:29\u201345.","journal-title":"Exp Neurol"},{"key":"369_CR29","doi-asserted-by":"crossref","first-page":"47373","DOI":"10.1074\/jbc.M208788200","volume":"277","author":"KJ Moore","year":"2002","unstructured":"Moore KJ, El Khoury J, Medeiros LA, Terada K, Geula C, Luster AD, et al. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem. 2002;277:47373\u20139.","journal-title":"J Biol Chem"},{"key":"369_CR30","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.4049\/jimmunol.170.11.5764","volume":"170","author":"I Farkas","year":"2003","unstructured":"Farkas I, Takahashi M, Fukuda A, Yamamoto N, Akatsu H, Baranyi L, et al. Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer\u2019s disease. J Immunol. 2003;170:5764\u201371.","journal-title":"J Immunol"},{"key":"369_CR31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0923-2494(92)80046-N","volume":"143","author":"J Rogers","year":"1992","unstructured":"Rogers J, Schultz J, Brachova L, Lue LF, Webster S, Bradt B, et al. Complement activation and beta-amyloid-mediated neurotoxicity in Alzheimer\u2019s disease. Res Immunol. 1992;143:624\u201330.","journal-title":"Res Immunol"},{"key":"369_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-5728(00)00404-5","volume":"113","author":"AM Szczepanik","year":"2001","unstructured":"Szczepanik AM, Funes S, Petko W, Ringheim GE. IL-4, IL-10 and IL-13 modulate A beta(1--42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol. 2001;113:49\u201362.","journal-title":"J Neuroimmunol"},{"key":"369_CR33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuroscience.2005.04.029","volume":"134","author":"S Rosi","year":"2005","unstructured":"Rosi S, Pert CB, Ruff MR, McGann-Gramling K, Wenk GL. Chemokine receptor 5 antagonist D-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer\u2019s disease. Neuroscience. 2005;134:671\u20136.","journal-title":"Neuroscience"},{"key":"369_CR34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1471-4159.2001.t01-1-00240.x","volume":"77","author":"AM Szczepanik","year":"2001","unstructured":"Szczepanik AM, Rampe D, Ringheim GE. Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo. J Neurochem. 2001;77:304\u201317.","journal-title":"J Neurochem"},{"key":"369_CR35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/JAD-2010-1219","volume":"19","author":"EG McGeer","year":"2010","unstructured":"McGeer EG, McGeer PL. Neuroinflammation in Alzheimer\u2019s disease and mild cognitive impairment: a field in its infancy. J Alzheimers Dis. 2010;19:355\u201361.","journal-title":"J Alzheimers Dis"},{"key":"369_CR36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/exnr.1999.7199","volume":"160","author":"R Veerhuis","year":"1999","unstructured":"Veerhuis R, Janssen I, De Groot CJ, Van Muiswinkel FL, Hack CE, Eikelenboom P. Cytokines associated with amyloid plaques in Alzheimer\u2019s disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Exp Neurol. 1999;160:289\u201399.","journal-title":"Exp Neurol"},{"key":"369_CR37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11064-012-0939-2","volume":"38","author":"J Li","year":"2013","unstructured":"Li J, Yang JY, Yao XC, Xue X, Zhang QC, Wang XX, et al. Oligomeric Abeta-induced microglial activation is possibly mediated by NADPH oxidase. Neurochem Res. 2013;38:443\u201352.","journal-title":"Neurochem Res"},{"key":"369_CR38","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2174\/18715273113129990072","volume":"12","author":"M Sochocka","year":"2013","unstructured":"Sochocka M, Koutsouraki ES, Gasiorowski K, Leszek J. Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer\u2019s disease: a new approach to therapy. CNS Neurol Disord Drug Targets. 2013;12:870\u201381.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"369_CR39","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1126\/science.1162844","volume":"321","author":"MA Busche","year":"2008","unstructured":"Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease. Science. 2008;321:1686\u20139.","journal-title":"Science"},{"key":"369_CR40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1471-4159.2010.06637.x","volume":"113","author":"LO Brandenburg","year":"2010","unstructured":"Brandenburg LO, Konrad M, Wruck CJ, Koch T, Lucius R, Pufe T. Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells. J Neurochem. 2010;113:749\u201360.","journal-title":"J Neurochem"},{"key":"369_CR41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0304-3940(95)11384-9","volume":"188","author":"R Bo Del","year":"1995","unstructured":"Del Bo R, Angeretti N, Lucca E, De Simoni MG, Forloni G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci Lett. 1995;188:70\u20134.","journal-title":"Neurosci Lett"},{"key":"369_CR42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12264-011-1205-3","volume":"27","author":"Y Feng","year":"2011","unstructured":"Feng Y, Li L, Sun XH. Monocytes and Alzheimer\u2019s disease. Neurosci Bull. 2011;27:115\u201322.","journal-title":"Neurosci Bull"},{"key":"369_CR43","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J Neurosci. 2008;28:8354\u201360.","journal-title":"J Neurosci"},{"key":"369_CR44","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1021\/bi000169p","volume":"39","author":"H Misonou","year":"2000","unstructured":"Misonou H, Morishima-Kawashima M, Ihara Y. Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry. 2000;39:6951\u20139.","journal-title":"Biochemistry"},{"key":"369_CR45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0169-328X(97)00356-2","volume":"55","author":"GE Ringheim","year":"1998","unstructured":"Ringheim GE, Szczepanik AM, Petko W, Burgher KL, Zhu SZ, Chao CC. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor\/interleukin-6 complex. Brain Res Mol Brain Res. 1998;55:35\u201344.","journal-title":"Brain Res Mol Brain Res"},{"key":"369_CR46","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/sj.emboj.7601004","volume":"25","author":"Y Rahpeymai","year":"2006","unstructured":"Rahpeymai Y, Hietala MA, Wilhelmsson U, Fotheringham A, Davies I, Nilsson AK, et al. Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J. 2006;25:1364\u201374.","journal-title":"EMBO J"},{"key":"369_CR47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1742-2094-9-137","volume":"9","author":"FH Brennan","year":"2012","unstructured":"Brennan FH, Anderson AJ, Taylor SM, Woodruff TM, Ruitenberg MJ. Complement activation in the injured central nervous system: another dual-edged sword? J Neuroinflammation. 2012;9:137.","journal-title":"J Neuroinflammation"},{"key":"369_CR48","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/icb.2010.48","volume":"88","author":"MJ Rutkowski","year":"2010","unstructured":"Rutkowski MJ, Sughrue ME, Kane AJ, Mills SA, Fang S, Parsa AT. Complement and the central nervous system: emerging roles in development, protection and regeneration. Immunol Cell Biol. 2010;88:781\u20136.","journal-title":"Immunol Cell Biol"},{"key":"369_CR49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12017-009-8085-y","volume":"12","author":"TM Woodruff","year":"2010","unstructured":"Woodruff TM, Ager RR, Tenner AJ, Noakes PG, Taylor SM. The role of the complement system and the activation fragment C5a in the central nervous system. Neuromolecular Med. 2010;12:179\u201392.","journal-title":"Neuromolecular Med"},{"key":"369_CR50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1471-4159.2001.00167.x","volume":"77","author":"P Mukherjee","year":"2001","unstructured":"Mukherjee P, Pasinetti GM. Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3. J Neurochem. 2001;77:43\u20139.","journal-title":"J Neurochem"},{"key":"369_CR51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-5-5","volume":"5","author":"P Mukherjee","year":"2008","unstructured":"Mukherjee P, Thomas S, Pasinetti GM. Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo. J Neuroinflammation. 2008;5:5.","journal-title":"J Neuroinflammation"},{"key":"369_CR52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/(SICI)1097-4644(19990601)73:3<303::AID-JCB2>3.0.CO;2-2","volume":"73","author":"H Osaka","year":"1999","unstructured":"Osaka H, Mukherjee P, Aisen PS, Pasinetti GM. Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J Cell Biochem. 1999;73:303\u201311.","journal-title":"J Cell Biochem"},{"key":"369_CR53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1460-9568.2008.06575.x","volume":"29","author":"M Persson","year":"2009","unstructured":"Persson M, Pekna M, Hansson E, Ronnback L. The complement-derived anaphylatoxin C5a increases microglial GLT-1 expression and glutamate uptake in a TNF-alpha-independent manner. Eur J Neurosci. 2009;29:267\u201374.","journal-title":"Eur J Neurosci"},{"key":"369_CR54","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1074\/jbc.M112.400168","volume":"288","author":"ME Benoit","year":"2013","unstructured":"Benoit ME, Hernandez MX, Dinh ML, Benavente F, Vasquez O, Tenner AJ. C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-beta neurotoxicity. J Biol Chem. 2013;288:654\u201365.","journal-title":"J Biol Chem"},{"key":"369_CR55","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/glia.22331","volume":"60","author":"H Fu","year":"2012","unstructured":"Fu H, Liu B, Frost JL, Hong S, Jin M, Ostaszewski B, et al. Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Abeta by microglia. Glia. 2012;60:993\u20131003.","journal-title":"Glia"},{"key":"369_CR56","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbi.2004.01.004","volume":"18","author":"VH Perry","year":"2004","unstructured":"Perry VH. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun. 2004;18:407\u201313.","journal-title":"Brain Behav Immun"},{"key":"369_CR57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","volume":"10","author":"VH Perry","year":"2014","unstructured":"Perry VH, Holmes C. Microglial priming in neurodegenerative disease. Nat Rev Neurol. 2014;10:217\u201324.","journal-title":"Nat Rev Neurol"},{"key":"369_CR58","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0306-4522(97)00165-6","volume":"80","author":"EH Owen","year":"1997","unstructured":"Owen EH, Logue SF, Rasmussen DL, Wehner JM. Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analyses. Neuroscience. 1997;80:1087\u201399.","journal-title":"Neuroscience"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-015-0369-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T07:40:05Z","timestamp":1567064405000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jneuroinflammation.com\/content\/12\/1\/150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,16]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["369"],"URL":"https:\/\/doi.org\/10.1186\/s12974-015-0369-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,16]]},"article-number":"150"}}